跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
FORTASEC FLAS 2 mg LIOFILIZADO ORAL - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
FORTASEC FLAS 2 mg LIOFILIZADO ORAL
Approved
STANDARD
FORTASEC FLAS 2 mg LIOFILIZADO ORAL
Johnson & Johnson Consumer
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Aug 27, 2026
Approval ID
925f47644db674a3
Company
Johnson & Johnson Consumer
Type
Standard
Approval Details
Approval Id
925f47644db674a3
Drug Cima Aemps Name
FORTASEC FLAS 2 mg LIOFILIZADO ORAL
Register Number
BE181422
Holder Company Name
Johnson & Johnson Consumer
Marketing Company Name
Difarmed S.L.U.
Authorization Date
2026-08-27
Dosage Form
LIOFILIZADO ORAL
Dose
2 mg de Loperamida hidrocloruro
Route Of Administration
VÍA ORAL
Prescription Type
Sin Receta
Commercialized
No
Company Name
Johnson & Johnson Consumer
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Aug 27, 2026
Approval ID
925f47644db674a3
Type
Standard
Back to CIMA-AEMPS Approvals